Alignment Healthcare (ALHC) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.25 per share a year ago.
Alignment Healthcare (ALHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Alignment Healthcare (ALHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants John Kao - Founder & Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants Scott Fidel - Stephens Adam Ron - Bank of America Michael Ha - Baird Matthew Gillmor - KeyBanc Capital Markets Jessica Tassan - Piper Sandler Operator Good afternoon, and welcome to Alignment Healthcare's Fourth Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions].
The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alignment Healthcare (ALHC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.25 per share a year ago.
Get a deeper insight into the potential performance of Alignment Healthcare (ALHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth.
Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants John Kao - Founder & Chief Executive Officer Thomas Freeman - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Matthew Dale Gillmor - KeyBanc Capital Markets Adam Ron - Bank of America John Ransom - Raymond James Whit Mayo - Leerink Partners Jessica Tassan - Piper Sandler Craig Jones - Stifel Operator Good afternoon and welcome to Alignment Healthcare Third Quarter 2024 Earnings Conference Call and Webcast. All participants will be in a listen-only mode.
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 per share a year ago.
Alignment Healthcare Tuesday reported a net loss in its third quarter of $26.4 million even as the startup provider of Medicare Advantage coverage to seniors experienced a nearly 58% increase in health plan members.